brand brand
Collapse

Europe Drug Class - Myasthenia Gravis Treatment Market Statistics

drug class myasthenia gravis treatment market size was valued at US$ 416.6 million in 2024 and is estimated to grow at a compound annual growth rate (CAGR) of 3% from 2024 to 2045.

  • Select file type

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe myasthenia gravis treatment market statistics, 2022-2045 (US$M)

Europe myasthenia gravis treatment market statistics, 2022-2045 (US$M)

Related Statistics

Complement Inhibitors - Myasthenia Gravis Treatment Market, 2024 - 2045 (USD Million)

FcRn Inhibitors - Myasthenia Gravis Treatment Market, 2024 - 2045 (USD Million)

Cholinesterase Inhibitors - Myasthenia Gravis Treatment Market, 2024 - 2045 (USD Million)

Others - Myasthenia Gravis Treatment Market, 2024 - 2045 (USD Million)

Soliris (Eculizumab) - Myasthenia Gravis Treatment Market, 2024 - 2045 (USD Million)

Ultomiris (Ravulizumab) - Myasthenia Gravis Treatment Market, 2024 - 2045 (USD Million)

Zilbrysq (Zilucoplan) - Myasthenia Gravis Treatment Market, 2024 - 2045 (USD Million)

Vyvgart (Efgartigimod) - Myasthenia Gravis Treatment Market, 2024 - 2045 (USD Million)

Rozanolixizumab - Myasthenia Gravis Treatment Market, 2024 - 2045 (USD Million)

Pyridostigmine Bromide (Mestinon) - Myasthenia Gravis Treatment Market, 2024 - 2045 (USD Million)

Neostigmine - Myasthenia Gravis Treatment Market, 2024 - 2045 (USD Million)

Corticosteroids - Myasthenia Gravis Treatment Market, 2024 - 2045 (USD Million)

Non-Steroidal Immunosuppressants - Myasthenia Gravis Treatment Market, 2024 - 2045 (USD Million)

Purine Analogs - Myasthenia Gravis Treatment Market, 2024 - 2045 (USD Million)

Branded - Myasthenia Gravis Treatment Market, 2024 - 2045 (USD Million)

Generics - Myasthenia Gravis Treatment Market, 2024 - 2045 (USD Million)

Hospital Pharmacies - Myasthenia Gravis Treatment Market, 2024 - 2045 (USD Million)

Retail Pharmacies - Myasthenia Gravis Treatment Market, 2024 - 2045 (USD Million)

Online Pharmacies - Myasthenia Gravis Treatment Market, 2024 - 2045 (USD Million)

Myasthenia Gravis Treatment Market Scope

Myasthenia gravis treatment market segmentation & scope
Drug Class
Complement Inhibitors
Soliris (Eculizumab)
Ultomiris (Ravulizumab)
Zilbrysq (Zilucoplan)
Veopoz (Pozelimab)
Gefurulimab
FcRn Inhibitors
Vyvgart (Efgartigimod)
Rozanolixizumab
Batoclimab
Other FcRn Inhibitors
Cholinesterase Inhibitors
Pyridostigmine Bromide (Mestinon)
Neostigmine
Cell Therapies
CAR-T Cell Therapy
T-Cell Receptor Therapy
Anti-CD19 Monoclonal Antibodies (mAbs)
Others
Corticosteroids
Non-Steroidal Immunosuppressants
Purine Analogs
Type
Branded
Generics
Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regions
Latin America
Middle East & Africa
Europe
North America
Asia Pacific
Countries
U.S.
Canada
Germany
UK
France
Italy
Spain
Japan
China
Australia
India
South Korea
Argentina
Brazil
Saudi Arabia
South Africa
Mexico
Sweden
Norway
Thailand
UAE
Kuwait
report
Myasthenia Gravis Treatment Market Outlook
  • PDF
  • HTML
  • PPT
  • -
Everything on Myasthenia Gravis Treatment Market in one document: edited and divided into chapters, including detailed references.

Related industry reports

Global Attention Deficit Hyperactivity Disorder Market Outlook, 2023-2030

Global Alzheimers Therapeutics Market Outlook, 2022-2030

Global Central Nervous System Therapeutic Market Outlook, 2020-2028

Global Narcolepsy Therapeutics Market Outlook, 2023-2030

Global Dementia Treatment Market, 2023-2030

Related Regional Reports

Global Myasthenia Gravis Treatment Industry Outlook

North America Myasthenia Gravis Treatment Market Outlook, 2025-2045

U.S. Myasthenia Gravis Treatment Market Outlook, 2025-2045

Canada Myasthenia Gravis Treatment Market Outlook, 2025-2045

Mexico Myasthenia Gravis Treatment Market Outlook, 2025-2045

Europe Myasthenia Gravis Treatment Market Outlook, 2025-2045

Germany Myasthenia Gravis Treatment Market Outlook, 2025-2045

France Myasthenia Gravis Treatment Market Outlook, 2025-2045

Italy Myasthenia Gravis Treatment Market Outlook, 2025-2045

Spain Myasthenia Gravis Treatment Market Outlook, 2025-2045

UK Myasthenia Gravis Treatment Market Outlook, 2025-2045

Sweden Myasthenia Gravis Treatment Market Outlook, 2025-2045

Norway Myasthenia Gravis Treatment Market Outlook, 2025-2045

Asia Pacific Myasthenia Gravis Treatment Market Outlook, 2025-2045

Japan Myasthenia Gravis Treatment Market Outlook, 2025-2045

China Myasthenia Gravis Treatment Market Outlook, 2025-2045

India Myasthenia Gravis Treatment Market Outlook, 2025-2045

Australia Myasthenia Gravis Treatment Market Outlook, 2025-2045

South Korea Myasthenia Gravis Treatment Market Outlook, 2025-2045

Thailand Myasthenia Gravis Treatment Market Outlook, 2025-2045

Latin America Myasthenia Gravis Treatment Market Outlook, 2025-2045

Argentina Myasthenia Gravis Treatment Market Outlook, 2025-2045

Brazil Myasthenia Gravis Treatment Market Outlook, 2025-2045

MEA Myasthenia Gravis Treatment Market Outlook, 2025-2045

South Africa Myasthenia Gravis Treatment Market Outlook, 2025-2045

Saudi Arabia Myasthenia Gravis Treatment Market Outlook, 2025-2045

UAE Myasthenia Gravis Treatment Market Outlook, 2025-2045

Kuwait Myasthenia Gravis Treatment Market Outlook, 2025-2045

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online